These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6518323)

  • 21. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of the treatment course and organization in chronic alcoholism in pulmonary tuberculosis patients].
    Utkin VV; Drozdov ES; Ognev AE; Mikheeva LP
    Probl Tuberk; 1981 Oct; (10):9-12. PubMed ID: 7312862
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K; McElroy PD; Jereb J; Navin TR; Castro KG
    Clin Infect Dis; 2007 Feb; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid].
    Uçak D; Uçak A
    Tip Fak Mecm; 1969; 32(1):48-52. PubMed ID: 5398987
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S; Armas Merino R; Busel I; Baier E; Wolff C; Jabsa Z
    Rev Med Chil; 1981 Mar; 109(3):212-20. PubMed ID: 7280406
    [No Abstract]   [Full Text] [Related]  

  • 26. [Side effects of antitubercular drugs in patients with pulmonary tuberculosis and chronic alcoholism].
    Rudoĭ NM; Chubakov TCh
    Sov Med; 1984; (8):7-10. PubMed ID: 6494999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of sulfozine to treat chronic alcoholism in pulmonary tuberculosis].
    Kalabukha AV; Kalabukha VA
    Probl Tuberk; 1981 Mar; (3):38-41. PubMed ID: 7232391
    [No Abstract]   [Full Text] [Related]  

  • 28. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W; Lindemann I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):87-98. PubMed ID: 5197904
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pyrogenic agents in the therapy of pulmonary tuberculosis patients suffering from alcoholism].
    Kalabukha VA; Kalabukha AV
    Probl Tuberk; 1985; (4):38-41. PubMed ID: 4001107
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional state of the liver in patients with pulmonary tuberculosis against a background of antibacterial therapy].
    Latyshev NN
    Probl Tuberk; 1967; 45(9):54-8. PubMed ID: 5606480
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antioxidant treatment of pulmonary tuberculosis in patients with chronic alcoholism].
    Burnusus ZI
    Probl Tuberk; 1992; (5-6):28-30. PubMed ID: 1409509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver function and antitubercular agents. Results of a polycentric study with various chemo-antibiotic combinations].
    Grassi C; Mainardi L; Pasquariello G; Bissanti A; Luvarà A; Pozzi E
    G Ital Chemioter; 1973; 20(1-4):1-14. PubMed ID: 4619078
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of tuberculosis in persons with mental diseases].
    Shcherbatiuk AS; Sabanov AI
    Probl Tuberk; 1980 Jan; (1):48-51. PubMed ID: 7367424
    [No Abstract]   [Full Text] [Related]  

  • 36. Moxifloxacin-induced arthropathy.
    Wong HY; Chau CH; Yew WW
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):117. PubMed ID: 17217142
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of alpha-tocopherol in eliminating and preventing the hepatotoxic action of tuberculostatics].
    Grechin SA; Suslov EI; Mel'nik VP; Shuripa VP; Protsiuk RG
    Vrach Delo; 1987 Mar; (3):60-2. PubMed ID: 3590706
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness of treating patients with pulmonary tuberculosis and alcoholism].
    Kobeleva GV
    Sov Med; 1987; (4):106-8. PubMed ID: 2885924
    [No Abstract]   [Full Text] [Related]  

  • 39. [State of the liver in middle-aged and elderly patients with pulmonary tuberculosis under prolonged chemotherapy].
    Iashchenko BP; Iakimets VP
    Vrach Delo; 1971 Oct; 10():86-90. PubMed ID: 5142544
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V; Klapálek D; Paichl P; Pecený A
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.